Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 7;54(2):e37-e43.
doi: 10.1093/labmed/lmac089.

Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection

Xuewen Li  1 , Yiting Wang  1 , Junqi Pan  2 , Jiancheng Xu  1 , Qi Zhou  3
Affiliations
Review

Combined Diagnosis of SARS-CoV-2: Rapid Antigen Detection as an Adjunct to Nucleic Acid Detection

Xuewen Li et al. Lab Med. .

Abstract

Coronavirus disease 2019 is a serious threat to human life, and early diagnosis and screening can help control the COVID-19 pandemic. The high sensitivity of reverse transcriptase-polymerase chain reaction (RT-PCR) assay is the gold standard for the diagnosis of COVID-19, but there are still some false-negative results. Rapid antigen detection (RAD) is recommended by the World Health Organization (WHO) as a screening method for COVID-19. This review analyzed the characteristics of RDT and found that although the overall sensitivity of RAD was not as high as that of RT-PCR, but RAD was more sensitive in COVID-19 patients within 5 days of the onset of symptoms and in COVID-19 patients with Ct ≤ 25. Therefore, RAD can be used as an adjunct to RT-PCR for screening patients with early COVID-19. Finally, this review provides a combined diagnostic protocol for RAD and nucleic acid testing with the aim of providing a feasible approach for COVID-19 screening.

Keywords: COVID-19; Early screening; Lateral flow immunoassay; RT-PCR; Sensitivity.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
A, Sensitivity of different LFIA kits in COVID-19 patients at different days after the onset of symptoms. B, Sensitivity of different LFIA kits for Ct values in different ranges of RT-PCR. The legend indicates the types of kits used in the different references.
FIGURE 2
FIGURE 2
Flow chart of the combined detection of SARS-COV-2 using NAAT and RAD in different populations. NAAT, nucleic acid amplification test; RAD, rapid antigen detection.
See this image and copyright information in PMC

References

    1. World Health Organization (WHO): Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed March 13, 2022.
    1. Mathuria JP, Yadav R. Rajkumar. Laboratory diagnosis of SARS-CoV-2 - a review of current methods. J Infect Public Health. 2020;13(7):901–905. doi: 10.1016/j.jiph.2020.06.005. - DOI - PMC - PubMed
    1. World Health Organization (WHO): Coronavirus Disease (COVID-19) Pandemic — Emergency Use Listing Procedure (EUL) Open for IVDs. https://extranet.who.int/pqweb/vitro-diagnostics/coronavirus-disease-cov.... Accessed March 13, 2022.
    1. US Centers for Disease Control and Prevention. Interim Guidance for Rapid Antigen Testing for SARS-CoV-2. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-gu.... Accessed March 13, 2022.
    1. European Centre for Disease Prevention and Control. Options for the Use of Rapid Antigen Tests for COVID-19 in the EU/EEA and the UK. (https://www.ecdc.europa.eu/en/publications-data/options-use-rapid-antige...). Accessed 13 March 2022.